The FSP model in Thailand is rapidly transforming how global clinical trials are conducted by combining local expertise with international best practices. In this model, dedicated teams in Thailand handle specific trial functions, helping sponsors achieve faster approvals, smoother site management, and better patient recruitment. We will discuss this model in detail throughout the article, […]
Read More →The nutraceutical industry has experienced significant growth in recent years, fueled by rising consumer demand for dietary supplements, functional foods, and natural health products. However, with this expansion comes heightened scrutiny from regulatory bodies, highlighting the challenges in nutraceutical clinical trials as a crucial aspect of successfully bringing new products to market. Unlike pharmaceuticals, nutraceuticals […]
Read More →South Korea has rapidly emerged as a leading destination for clinical trials, attracting global pharmaceutical companies and research organizations with its advanced healthcare infrastructure, cutting-edge technology, and highly skilled medical professionals. As one of the most innovative countries in the world, South Korea offers a dynamic environment for clinical research, characterized by : However, like […]
Read More →In clinical research, understanding the distinctions between rare and standard disease trials is crucial for optimizing study design and execution. Rare disease trials focus on conditions that affect a small percentage of the population, while standard disease trials target more prevalent conditions. However, both types of trials are equally important in advancing medical science and […]
Read More →Bioavailability and bioequivalence (BA/BE) studies in the Asia-Pacific region are gaining significant momentum. The rising cost of medicines worldwide is driving a strong demand for more affordable healthcare options. In this context, the generic drug market is emerging as a promising alternative, offering consumers access to medications at more reasonable prices. To bring generic drugs […]
Read More →Pharmaceutical research and development in the Asia-Pacific (APAC) region now heavily relies on clinical trial sourcing. Collaborating with research institutions and healthcare organizations fosters international research partnerships and facilitates knowledge exchange. Most countries in the Asia-Pacific region tend to seek this help because it brings several benefits. The success of clinical trials depends on the […]
Read More →The APAC region has had a remarkable increase in oncology clinical trial activity, and it is currently leading the world in the overall number of ongoing oncology clinical studies. The Asia-Pacific region has emerged as an epicenter of clinical trial activity, accounting for over half of total global clinical trials. With these growth tendencies projected […]
Read More →The Asia-Pacific region, with over half of the global population, is becoming a growing popular spot for conducting clinical trials by offering lower trial costs, access to large patient pools, and a friendly regulatory environment. These distinguishing traits are increasing interest in medical device, pharmaceutical, and healthcare companies to shift their clinical trial locations to […]
Read More →The Asia-Pacific region emerges as a pivotal player in the landscape of clinical trials. They offer unique advantages for conducting impactful research due to diverse populations, varied healthcare infrastructures, and a rich pool of treatment-naive patients. Over the past decade, there has been a notable shift in the global Phase I clinical trials scenario, with […]
Read More →Clinical trials in rare diseases present more significant challenges compared to trials in more common diseases. These challenges arise due to various factors, including trial design, the limited patient population for recruitment, regulatory support, and more. However, implementing a well-defined strategy for clinical development in rare diseases can help overcome these challenges. Such a strategy […]
Read More →